Patents Assigned to L'Universite Paris Descartes
  • Polypeptides and nucleic acids for treating ErbB2-dependent cancers
    Patent number: 9127077
    Abstract: The present invention relates to polypeptides, nucleic acids and pharmaceutical compositions suitable for use in the treatment of ErbB2 dependent-cancers, in particular of tumors overexpressing ErbB2 or expressing mutated forms of the ErbB2 gene.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: September 8, 2015
    Assignee: L'Universite Paris Descartes
    Inventors: Sandrine Bourdoulous, Rym Djerbi-Bouillie